IGF-1LR3 — research reference, shipped from Colombia

Presentations and visible prices

The price above is the public value per vial. Availability and batch documentation are confirmed before the quotation is accepted.

One of the smallest presentations in the catalog

0.1 mg is one of the smallest mass units declared in the catalog: an order of magnitude below presentations such as PTD-DBM's 1 mg or AOD9604's and MGF's 2 mg. That difference in scale does not change the material's physical form, but it matters for anyone placing an order: the exact presentation should be recorded without rounding across the request, the quotation, and the receiving label.

The second presentation, 1 mg, is ten times the declared mass of the 0.1 mg one. Both share the same structural classification and the same commercial category; what distinguishes one from the other is exclusively the mass per vial. The price of each is confirmed separately in the pricing block on this page.

83 amino acids and an N-terminal extension: what that classification states

The technical sheet describes IGF-1LR3 as an 83-amino-acid IGF-1 analog with an N-terminal extension. That description points to chain length and a structural modification at a specific end of the molecule; it is a biochemical classification, not a claim about what occurs in an organism.

Within Growth Hormone and Secretagogues, IGF-1LR3 is the only reference classified as an IGF-1 analog. The others belong to distinct families: GHRH analogs such as Sermorelin, CJC-1295 With DAC, and Tesamorelin, or hexapeptide secretagogues such as GHRP-2, GHRP-6, and Hexarelin. They share a research axis, not a structure.

Two IGF-1LR3 presentations: what to state in each line item

The GH/IGF-1 and secretagogues axis brings together twelve catalog references, spanning designed peptides, GHRH analogs, and hexapeptide secretagogues. The current price for each IGF-1LR3 presentation — 0.1 mg and 1 mg — appears separately in the pricing block on this page.

That price should be confirmed there before approving any quotation, with the exact milligram figure for each line item, without assuming it matches another reference in the same axis or a prior inquiry.

The Janoshik COA and the data left pending

IGF-1LR3's certificate of analysis is issued by Janoshik Analytical, per batch, with mass spectrometry (MS) for identity and high-performance liquid chromatography (HPLC) for purity. The certificate is handled on request and subject to documentary availability, and should correspond to the specific batch dispatched, not to a general statement about the reference.

CAS number, molecular formula, molecular weight, and the exact purity percentage are not filled in this text: they remain visibly pending in the technical block of the page, referred to the batch's COA, for both the 0.1 mg and the 1 mg presentation.

Lyophilized powder at two mass scales

Both presentations are declared by mass, so both correspond to lyophilized powder in a vial, with declared origin in the United States. Shipping cost is the same for either presentation, since it does not depend on the declared mass per vial; see the site's shipping information for current rates to Bogotá and the rest of the country. Delivery date is not fixed on this page: it is agreed at the time of quotation, depending on destination. Outside Colombia, this reference ships to 5 countries (Costa Rica, Ecuador, United States, Mexico and Puerto Rico), from US$57; the rate for each country is listed on the site's international shipping page.

Storage follows the documentation applicable to the batch; if it specifies 2–8 °C and protection from light, that condition applies equally to the 0.1 mg and the 1 mg presentation, and should be ready at the receiving institution before dispatch.

From quoting either presentation to the record

An IGF-1LR3 order, in either of its two presentations, does not trigger an automatic charge: the request is registered, the quotation is confirmed with the payment method and total defined, and only then is payment coordinated. The chosen presentation should be explicit in every document in the process.

The final file can bring together the quotation, payment, dispatch, receipt, and the Janoshik COA if it was requested. This page is limited to that documentary chain and to IGF-1LR3's classification as research material, without extending its scope to any other use.

Frequently asked questions about IGF-1LR3